TALEN

TALEN1-shha

ID
ZDB-TALEN-170929-2
Name
TALEN1-shha
Previous Names
None
Target
Target Sequence 1
5' - AGACTATATCGTTTG - 3'
Target Sequence 2
5' - TCACTTCATTGTGTT - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
None
Target Location
Constructs
No data available
Genomic Features
Genomic Feature Affected Genomic Regions
vcc8Gt shha
Expression
Gene expression in Wild Types + TALEN1-shha
No data available
Phenotype
Phenotype resulting from TALEN1-shha
No data available
Phenotype of all Fish created by or utilizing TALEN1-shha
Phenotype Fish Conditions Figures
whole organism shha expression decreased amount, abnormal shhavcc8Gt/+ ; vcc9Tg/+ (EKW) control Fig. 3 S2 with image from Sugimoto et al., 2017
heart aldh1a2 expression decreased amount, abnormal shhavcc8Gt/vcc8Gt ; pd42Tg/+ (EKW) chemical treatment by environment: tamoxifen Fig. 4 with image from Sugimoto et al., 2017
ventricular myocardium decreased thickness, abnormal shhavcc8Gt/vcc8Gt ; pd42Tg/+ (EKW) chemical treatment by environment: tamoxifen Fig. 4 with image from Sugimoto et al., 2017
heart edematous, abnormal shhavcc8Gt/vcc8Gt ; pd42Tg/+ (EKW) chemical treatment by environment: tamoxifen Fig. 4 with image from Sugimoto et al., 2017
heart shha expression absent, abnormal shhavcc8Gt/vcc8Gt ; pd42Tg/+ (EKW) chemical treatment by environment: tamoxifen Fig. 4 with image from Sugimoto et al., 2017
heart fgf16 expression decreased amount, abnormal shhavcc8Gt/vcc8Gt ; pd42Tg/+ (EKW) chemical treatment by environment: tamoxifen Fig. 4 with image from Sugimoto et al., 2017
regenerating tissue cardiac muscle cell proliferation decreased occurrence, abnormal shhavcc8Gt/vcc8Gt ; pd42Tg/+ (EKW) amputation: cardiac ventricle, chemical treatment by environment: tamoxifen Fig. 5 with image from Sugimoto et al., 2017
heart ptch1 expression absent, abnormal shhavcc8Gt/vcc8Gt ; pd42Tg/+ (EKW) chemical treatment by environment: tamoxifen Fig. 4 with image from Sugimoto et al., 2017
heart fgf2 expression decreased amount, abnormal shhavcc8Gt/vcc8Gt ; pd42Tg/+ (EKW) chemical treatment by environment: tamoxifen Fig. 4 with image from Sugimoto et al., 2017
cardiac muscle cell decreased amount, abnormal shhavcc8Gt/vcc8Gt ; pd42Tg/+ (EKW) chemical treatment by environment: tamoxifen Fig. 4 with image from Sugimoto et al., 2017
heart wnt9b expression decreased amount, abnormal shhavcc8Gt/vcc8Gt ; pd42Tg/+ (EKW) chemical treatment by environment: tamoxifen Fig. 4 with image from Sugimoto et al., 2017
pectoral fin decreased size, abnormal shhavcc8Gt/vcc8Gt ; vcc9Tg/+ (EKW) standard conditions Fig. 3 S2 with image from Sugimoto et al., 2017
whole organism shha expression absent, abnormal shhavcc8Gt/vcc8Gt ; vcc9Tg/+ (EKW) control Fig. 3 S2 with image from Sugimoto et al., 2017
epicardium shha expression absent, abnormal shhavcc8Gt/vcc8Gt; pd37Tg/+; pd42Tg/+ (EKW) amputation: cardiac ventricle, chemical treatment by environment: tamoxifen Fig. 5 with image from Sugimoto et al., 2017
epicardium aldh1a2 expression absent, abnormal shhavcc8Gt/vcc8Gt; pd37Tg/+; pd42Tg/+ (EKW) chemical treatment by environment: tamoxifen Fig. 4 with image from Sugimoto et al., 2017
Citations